Luke Timmerman | The Seattle Times

FILE–University of Washington biologist Leroy Hood, shown here in Seattle in 1992, has been changing the way we view science. Hood is chairman of the school’s three-year-old department of molecular biotechnology, which was set up on a $12 million grant from Microsoft’s CEO Bill Gates.

August 11, 2016 at 5:31 pm

Biotech breakup: Lee Hood, Bill Gates and ‘a kick in the teeth’

Lee Hood, the visionary but often difficult biotech star lured by Bill Gates to the University of Washington, was about to jump ship — and...

January 18, 2008 at 12:00 am

Seattle biotech gets OK for drug

ZymoGenetics won U.S. approval to market its first product, a drug to stop excess bleeding in as many as 1 million surgeries a year. The...

Business

June 5, 2007 at 12:00 am

Provenge critics receive threats

Two cancer doctors have received threatening e-mails in recent weeks because of their opposition to Provenge, an experimental prostate-cancer...

Business

May 9, 2007 at 12:00 am

Dendreon shares plummet as FDA delays prostate cancer drug

Dendreon's shares plunged nearly 65 percent today, wiping out almost $1 billion in market value, after U.S. regulators said more information...

Business

April 28, 2007 at 12:00 am

Short-sellers are betting Dendreon won’t win FDA’s OK

Dendreon shares are being sold short at a record pace as some investors bet the company's experimental prostate-cancer drug will fail to...

Business

April 27, 2007 at 12:00 am

Short sellers bet Dendreon’s drug won’t win FDA approval

Dendreon shares are being sold short at a record pace as some investors bet the company's experimental prostate cancer drug will fail to...

Business

March 7, 2007 at 12:00 am

FDA allows ZymoGenetics to skip trial of spray drug, saving time and money

ZymoGenetics said regulators won't require a large clinical trial of a spray version of its treatment for bleeding during surgery, saving the company several million...

Business

January 20, 2007 at 12:00 am

Cancer doctors’ disclosure policy tightened

Cancer doctors must disclose all financial ties to investment firms, said a leading U.S. physician group seeking to stop the leak of insider...

Business

January 19, 2007 at 12:00 am

Lilly/Icos says sales of Cialis jumped 28 percent

Sales of Cialis climbed to a record $269.2 million in the fourth quarter, a 28 percent increase from a year earlier. The world's No. 2...

Business

January 18, 2007 at 12:00 am

Lilly Icos’ Cialis sales rise to record

Sales of Cialis, the world's No. 2 impotence drug, climbed to a record $269.2 million in the fourth quarter, a 28 percent increase from a...

Business